Pharmacotherapy, pharmacogenetics and pharmaceutical technology
PRINCIPAL INVESTIGATORS
- Pedro Alía Ramos
- Beatriz Candás Estébanez
- Helena Colom Codina
- Elisabet Leiva Badosa
- Josep Manel Llop Talaveron
CLINICAL RESEARCHERS
- Maria Bella Badia Tahull
- Encarna Garcia Montoya
- Roser Juvany Roig
- Núria Llecha Cano
- Montserrat Miñarro Carmona
- Ariadna Padró Miquel
- Ariadna Padullés Zamora
- Maria Pilar Pérez Lozano
- Khadija Rouaz El Hajoui
- Eugènia Santacana Juncosa
- Josep Maria Suñe Negre
- Marc Suñé Pou
- Josep Ramon Tico Grau
POSTDOCTORAL RESEARCHERS
- Ana Suarez-Lledo Grande
PREDOCTORAL RESEARCHERS
- Sara Cobo Sacristán
- Montserrat Colls Gonzalez
- Leticia Garrido Sanchez
- Javier Martínez Casanova
- Lorena Maria Santulario Verdu
SCIENTIFIC SUPPORT
- Sara Quiles Petidier
MANAGEMENT SUPPORT
- Laura Canals Vilaseca
- Ana Maria Ferrer Artola
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
Scientific production
33
PAPERS
Average IF: 4,48
13
LED PAPERS
Average IF: 3,52
11 PUBLICATIONS IN FIRST DECILE
20 PUBLICATIONS IN FIRST QUARTILE
26 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Ronda,M;Fuset,MP;Esteve Pitarch,E;Llop,J;Gumucio Sanguino,VD;Shaw,E;Mula,DM et al, Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX), Antibiotics-Basel, 2025;14(9):doi:10.3390/antibiotics14090939
- Canadell Heredia,R;Rouaz Hajoui,K;Franco Piedrahita,N;Perez Lozano,P;Suñé Pou,M;Suñé Negre,JM;Garcia Montoya,E, Preformulation Study of Carbamazepine Orally Disintegrating Tablets for Pediatric Patients Using Direct Compression and the SeDeM Diagram Tool: A Quality by Design Approach, Pharmaceutics, 2025;17(5):doi:10.3390/pharmaceutics17050624
- Silva,R;Colom,H;Almeida,A;Bicker,J;Carona,A;Silva,A;Sales,F et al, Population pharmacokinetics of levetiracetam in patients diagnosed with refractory epilepsy: A real-world study., Epilepsia, 2025;66(5):1505-1518, doi:10.1111/epi.18312
- Ruiz Ramos,J;Santolaya Perrín,R;García Martín,MÁ;Castellanos Clemente,Y;Alonso Díez,M;Lorenzo Pinto,A;Such Díaz,A et al, Acontecimientos adversos por medicamentos asociados a consultas a los servicios de urgencias., Emergencias, 2025;37(3):196-202, doi:10.55633/s3me/025.2025
- Silva,R;Colom,H;Almeida,A;Bicker,J;Carona,A;Silva,A;Sales,F et al, A new population pharmacokinetic model for dosing optimization of zonisamide in patients with refractory epilepsy, Eur. J. Pharm. Sci., 2025;207107023-107023, doi:10.1016/j.ejps.2025.107023
Research highlights
PROJECTS
4 Ongoing competitive projects
4 Started clinical trials
8 Ongoing clinical trials
PUBLISHED WORKS
2 Theses
NETWORKS
AGAUR SGR
ENOTTA
CIBERINFEC
Selected projects
- PR213/19. Antibiotic pharmacokinetic/pharmacodynamic target attaintment during continuous renal replacement therapy with a high absorptive membrane (oXiris®). VANITIVE US HEALTHCARE LLC. Budget: 9.760,37€. 2024-2026. PI: HELENA COLOM CODINA.
- HUB – RECCaracterización de las dislipemias poligénicas: de la teoría a la práctica. ERCA CLÍNICA – PADRO MIQUEL, ARIADNA. Hospital Universitario de Bellvitge. Budget: 20.000€. 2023-2027. PI: ARIADNA PADRÓ MIQUEL.
- PMP22/00119. RED NACIONAL DE LABORATORIOS DE FUNCION RENAL. Instituto de Salud Carlos III (ISCIII). Budget: 42.900€. 2023-2026. PI: PEDRO ALÍA RAMOS.
- PI21/00559. Aplicación de los modelos de cinética poblacional de tacrolimus en distintas poblaciones de trasplante. Papel de los polimorfismos del CYP3A en el trasplante de renal y trasplante hepático (adulto y pediátrico). Instituto de Salud Carlos III (ISCIII). Budget: 96.800€. 2022-2026. PI: HELENA COLOM CODINA.